Found 22 matching trials
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS PHASE1 This study is being done to evaluate the safety, tolerability and antitumor...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification PHASE2 This is a proof of concept, single-arm study to investigate crenolanib mono...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma PHASE1 This is a single-arm phase I/Ib study of crenolanib combined with ramucirum...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) PHASE1 The goal of Part 1 of this clinical research study is to learn if ponatinib...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas PHASE2 The purpose of this study is to evaluate the antitumor efficacy of crenolan...
Show More Location
Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Learn More & Join Trial
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. PHASE2 To determine the effectiveness of CP-868,596 + docetaxel, AG-013736 + docet...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations PHASE2 This is a Phase II open label study of crenolanib besylate. This study will...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients PHASE2 This is a single-arm, Phase II study of crenolanib as maintenance in AML pa...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations PHASE2 This pilot Phase II study is designed to evaluate the efficacy and tolerabi...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Individual Patient Compassionate Use of Crenolanib N/A Compassionate use of crenolanib for patients with serious life-threatening ...
Show More Location
Ospedale Policlinico San Martino
Learn More & Join Trial